This study provides a better insight into the role of LAT1 in the sesamol uptake in the hLAT1-HEK293 cells and also demonstrates that the chemical modification prodrug strategy of sesamol with a LAT1 substrate could overcome the low intracellular concentration of sesamol and increase its cellular potency in melanoma cells. The gene discussed is SLC7A5; the disease is melanoma.